| 產(chǎn)品標題 |
產(chǎn)品貨號 |
產(chǎn)品規(guī)格 |
廠家 |
| ?L(+)-Arabinose ≥98.0% | ?A0515-250G | | ?vwr |
| ?L(+)-Arabinose 99% | ?A11921-18 | | ?vwr |
| ?L(+)-Arabinose, high purity | ?1B1473-25G | | ?vwr |
| ?Hydroxy naphthol blue disodium salt, dark blue powder ACS | ?0215252910 | | ?vwr |
| ?Hydroxy naphthol blue disodium salt for Calcium determination | ?HX0847-3 | | ?vwr |
| ?2-Bromethylamine hydrobromide ≥98% | ?20101100GM | | ?vwr |
| ?L(+)-Arabinose ≥95% | ?075542-100G | | ?vwr |
| ?L(+)-Arabinose ≥99% for biochemistry | ?AC36518-1000 | | ?vwr |
| ?L(+)-Arabinose ≥99% | ?AC10498-5000 | | ?vwr |
| ?2-Bromethylamine hydrobromide ≥99% | ?AC10693-5000 | | ?vwr |
| ?2-Bromethylamine hydrobromide 98-101% (by titrimetric analysis) | ?14308-25G | | ?vwr |
| ?2-Bromethylamine hydrobromide ≥98% | ?20101100GM | | ?vwr |
| ?2-Bromethylamine hydrobromide ≥99% | ?AC10693-5000 | | ?vwr |
| ?2-Bromethylamine hydrobromide ≥99% | ?AC10693-5000 | | ?vwr |
| ?2-Bromethylamine hydrobromide ≥99% | ?AC10693-5000 | | ?vwr |
| ?2-Bromethylamine hydrobromide 98-101% (by titrimetric analysis) | ?14308-25G | | ?vwr |
| ?2-Bromethylamine hydrobromide ≥99% | ?AC10693-5000 | | ?vwr |
| ?2-Bromethylamine hydrobromide ≥95% | ?074880-100G | | ?vwr |
| ?8-Ethoxy-4,4,6-trimethyl-5,6-dihydro-4H-pyrrolo-[3,2,1-ij]quinoline-1,2-dione | ?065866-500MG | | ?vwr |
| ?2-Methyl-6-(4-methyl-piperidin-4-yl)-pyrimidine-4-carboxylic acid amide | ?068071-250MG | | ?vwr |
| ?Morpholine-4-carbothiohydrazide ≥95% | ?085709-1G | | ?vwr |
| ?1-(Bromomethyl)-4-propoxybenzene ≥97% | ?114108-1G | | ?vwr |
| ?2-Chloro-N-phenylacetamide | ?029452-500MG | | ?vwr |
| ?Methyl (S)-2-Isocyanato-3-phenylpropionate | ?038711-500MG | | ?vwr |
| ?3-Chloropyrazine-2-carbonyl chloride ≥97% | ?114559-1G | | ?vwr |
| ?Methyl (S)-2-Isocyanato-3-phenylpropionate ≥97.0% | ?I0472-5G | | ?vwr |
| ?N-(sec-Butyl)-N-(2-methoxybenzyl)amine ≥97% | ?081804-1G | | ?vwr |
| ?(R)-2-(Methoxymethyl)pyrrolidine hydrochloride ≥97% | ?114834-1G | | ?vwr |
| ?Diethyl-3-cyano-6-cyclopropyl-2,5-pyridinedicarboxylate ≥95% | ?054713-500MG | | ?vwr |
| ?tert-Butyl 5-oxo-D-prolinate ≥95% | ?075055-5G | | ?vwr |
| ?5-[1-(4-tert-Butylphenoxy)ethyl]-4-methyl-4H-1,2,4-triazole-3-thiol | ?030611-500MG | | ?vwr |
| ?1-[5-(Aminosulfonyl)-1,3-benzoxazol-2-yl]-piperidine-4-carboxylic acid | ?035879-500MG | | ?vwr |
| ?3-Isopropoxy-N-[2-(2-methoxyphenoxy)propyl]aniline | ?031307-500MG | | ?vwr |
| ?2-{[(4-Methylphenyl)sulfonyl]amino}propanoic acid | ?008117-500MG | | ?vwr |
| ?4-(4-Methoxyphenyl)pyrimidin-2-amine | ?064933-500MG | | ?vwr |
| ?4-Amino-3-(4-methoxy-phenyl)-butyric acid hydrochloride | ?026320-500MG | | ?vwr |
| ?Methyl 1-(3,4-difluorobenzyl)-5-oxopyrrolidine-3-carboxylate ≥97% | ?083593-1G | | ?vwr |
| ?3-Ethyl 2-methyl 6-hydroxyoctahydroisoquinoline-2,3(1H)-dicarboxylate ≥97% | ?083549-1G | | ?vwr |
| ?2-[(5-Nitropyridin-2-yl)amino]ethanol hydrochloride | ?060443-500MG | | ?vwr |
| ?5-Bromo-3-nitro-1H-1,2,4-triazole | ?040724-500MG | | ?vwr |
| ?2-Dimethylamino-N-(2-piperidin-2-yl-ethyl)-acetamide dihydrochloride | ?067459-500MG | | ?vwr |
| ?2-(2-Benzylphenoxy)-5-bromoaniline | ?022917-500MG | | ?vwr |
| ?1-(4-Chlorophenyl)piperidin-4-one | ?062361-500MG | | ?vwr |
| ?Methyl 2-amino-4,5-dimethylthiophene-3-carboxylate | ?028833-500MG | | ?vwr |
| ?N-(1-Benzothien-2-ylmethyl)ethanamine hydrochloride | ?060830-500MG | | ?vwr |
| ?4-Bromotetrafluorophenol ≥97% | ?012838-5G | | ?vwr |
| ?N-[2-(4-Ethylphenoxy)ethyl]-3-methylaniline | ?031696-500MG | | ?vwr |
| ?N-(4-Chloro-2,5-dimethoxyphenyl)-2-cyanoacetamide | ?039728-500MG | | ?vwr |
| ?N-(2-Aminoethyl)methanesulfonamide hydrochloride | ?060517-500MG | | ?vwr |
| ?4-Amino-6-(6-methylpyridin-2-yl)-1,6-dihydro-1,3,5-triazine-2-thiol | ?039485-500MG | | ?vwr |